Engineered viruses have great potential as cancer treatments. However, the only currently approved viral therapy, T-vec (Talimogene laherparepvec), suffers from off-target effects that limit its use to intratumoral injection.
Researchers at Stanford have developed a rapid and efficient method for high-throughput genome editing using CRISPR/Cas9. The CRISPR/Cas9 system allows researchers to edit any site in an organism's genome.
Stanford inventors have developed technologies for improved islet transplantation using a bioscaffold platform that maintains islet health during and after their transplantation.
Stanford inventors have developed technologies for improved islet transplantation using a bioscaffold platform that maintains islet health during and after their transplantation.
Researchers at Stanford have developed a probe, NIRDye812, which improves contrast between healthy and diseased tissues for fluorescence-guided cancer surgery applications.
A team of Stanford researchers has invented a product that can be used to provide relief to patients with hyperhidrosis (excessive sweating), with a particular focus on palmar hyperhidrosis (excessive sweating of the hands).
Bioengineers in Prof. Stephen Quake's laboratory have developed an energy efficient, on-chip valve system for automated, multiplexed fluid control in a portable, low-cost microfluidics devices.
Stanford researchers have designed hydrogels that can be delivered to surgical sites in a patient's body for controlled and sustained release of bacteriophages to treat or prevent bacterial infections.
Researchers at Stanford have developed a magnetophoretic separation device (MSD) for isolating basophils and other rare cell types from a blood sample. The device applies exponentially increasing magnetic field strength to flowing magnetically tagged cells.